Avadel Pharmaceuticals PLC (AD - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AVDL Nasdaq 2834 https://www.avadel.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Avadel Pharmaceuticals PLC (AD

Avadel's stock falls 21% after disclosing new FDA request for experimental narcolepsy drug - May 26th, 2022 1:09 pm
Avadel to Present Clinical Data for FT218 at SLEEP 2022 - May 19th, 2022 12:00 pm
Avadel Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference - May 18th, 2022 12:00 pm
What You Need To Know About Avadel Pharmaceuticals plc's (NASDAQ:AVDL) Investor Composition - May 9th, 2022 2:05 pm
Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2022 Financial Results - May 9th, 2022 11:00 am
Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter Financial Results on May 9 - May 2nd, 2022 12:00 pm
Martello Announces Appointment of Jim Clark as Chief Financial Officer - Apr 28th, 2022 12:00 pm
Why Avadel Pharmaceuticals Stock Is Skyrocketing Today - Apr 26th, 2022 3:38 pm
Avadel Pharmaceuticals Provides Comment on Recent Trading Activity - Apr 26th, 2022 11:30 am
Avadel Pharmaceuticals Announces Interim Data from the Open-Label RESTORE Study at the 2022 American Academy of Neurology Annual Meeting - Apr 25th, 2022 12:00 pm
Avadel Pharmaceuticals Announces Publication of Positive Secondary Endpoint Data from Pivotal Phase 3 REST-ON Trial - Apr 6th, 2022 12:00 pm
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences - Mar 22nd, 2022 12:00 pm
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results - Mar 17th, 2022 11:00 am
Avadel Pharmaceuticals Announces Appointment of Brandi Robinson as Senior Vice President, Corporate Affairs - Mar 14th, 2022 8:30 pm
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2021 Financial Results on March 17th - Mar 14th, 2022 12:00 pm
Avadel Announces New Positive Data for Once-at-Bedtime FT218 for Narcolepsy and Once-Nightly Dosing Preference Among Patients and Clinicians at World Sleep 2022 - Mar 11th, 2022 12:00 pm
Avadel Pharmaceuticals to Present at the Oppenheimer 32nd Annual Healthcare Conference - Mar 10th, 2022 9:30 pm
Avadel to Present New Clinical Data at World Sleep 2022 - Mar 1st, 2022 12:00 pm
Is Avadel Pharmaceuticals (NASDAQ:AVDL) A Risky Investment? - Feb 22nd, 2022 4:40 pm
Avadel Pharmaceuticals Appoints Dr. Douglas Williamson as Chief Medical Officer - Feb 14th, 2022 12:00 pm